Home › Trial NCT06756451
This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.
- Trial IDNCT06756451
- StatusRecruiting
- PhasePhase 1
- Study typeInterventional
- SponsorNanjing RegeneCore Biotech Co., Ltd.
- Enrollment71
- Start date2025-03-25
- ConditionsHematologic Malignancies
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.